Resilience provides mediating effect of resilience between fear of progression and sleep quality in patients with hematological malignancies

Table 2 Relationship between general patient data and fear of progression

Projects	Number, n (%)	Score	t/F	P value
Sex
Male	49 (49)	36.46 ± 4.30	3.232	0.002
Female	51 (51)	39.65 ± 5.47
Age (yr)
≤ 35	34 (34)	38.69 ± 5.37	0.426	0.654
35-60	36 (36)	37.55 ± 3.83
≥ 60	30 (30)	38.04 ± 6.30
Marital status
Married	27 (27)	37.09 ± 4.55	0.190	0.827
Unmarried	48 (48)	39.19 ± 5.55
Divorce/widowhood	25 (25)	37.04 ± 4.74
Family per capita monthly income (RMB)
< 3000	32 (32)	41.71 ± 4.65	32.112	0.000
3000-5000	38 (38)	38.62 ± 3.27
> 5000	30 (30)	33.54 ± 4.23
Medical expenses payment method
Medical insurance	46 (46)	37.54 ± 5.09	0.896	0.412
Agricultural insurance	51 (51)	38.39 ± 5.14
Other	3 (3)	41.21 ± 7.24
Educational level
Junior high school and below	40 (40)	38.65 ± 4.75	3.189	0.046
High school/technical secondary school	41 (41)	38.76 ± 4.88
College degree or above	19 (19)	35.45 ± 5.98
Type of occupation
Employment	46 (46)	37.10 ± 4.39	1.782	0.078
Unemployment	54 (54)	38.93 ± 5.65
Type of residence
Rural	34 (34)	39.08 ± 4.09	1.396	0.166
Town	66 (66)	37.57 ± 5.60
Disease course
Less than 2 yr	50 (50)	37.64 ± 5.08	-0.859	0.393
2 yr and above	50 (50)	38.53 ± 5.26
Religious beliefs
Yes	5 (5)	37.99 ± 5.60	-0.806	0.422
No	95 (95)	39.90 ± 5.15
Family history
Yes	16 (16)	38.79 ± 4.41	-0.594	0.554
No	84 (84)	37.95 ± 5.30
Tumor type
Leukemia	29 (29)	39.15 ± 6.07	1.068	0.366
Lymphoma	30 (30)	37.95 ± 3.79
Multiple myeloma	21 (21)	36.54 ± 5.21
Myelodysplastic syndrome	20 (20)	38.38 ± 5.43